Association of polymorphisms of the oestrogen receptor alpha gene with the age of menarche.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 11925413)

Published in Hum Reprod on April 01, 2002

Authors

I Stavrou1, C Zois, J P A Ioannidis, A Tsatsoulis

Author Affiliations

1: Division of Endocrinology, Department of Internal Medicine, University of Ioannina School of Medicine, Ioannina 45110, Greece.

Articles citing this

Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37

Association studies of common variants in 10 hypogonadotropic hypogonadism genes with age at menarche. J Clin Endocrinol Metab (2008) 1.83

Determinants of menarche. Reprod Biol Endocrinol (2010) 1.23

A large-scale candidate gene association study of age at menarche and age at natural menopause. Hum Genet (2010) 1.22

Genome-wide association analyses identify SPOCK as a key novel gene underlying age at menarche. PLoS Genet (2009) 1.21

A genome-wide linkage scan for age at menarche in three populations of European descent. J Clin Endocrinol Metab (2008) 1.19

Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus. Ann Rheum Dis (2004) 1.00

Estrogen receptor alpha gene polymorphism and endometrial cancer risk--a case-control study. BMC Cancer (2008) 0.97

Timing of menarche in Chinese girls with and without adolescent idiopathic scoliosis: current results and review of the literature. Eur Spine J (2010) 0.97

Reported early family environment covaries with menarcheal age as a function of polymorphic variation in estrogen receptor-α. Dev Psychopathol (2011) 0.95

Genetic influences on adolescent sexual behavior: Why genes matter for environmentally oriented researchers. Psychol Bull (2013) 0.92

The chemokine (C-C-motif) receptor 3 (CCR3) gene is linked and associated with age at menarche in Caucasian females. Hum Genet (2006) 0.89

ESR1 polymorphism is associated with plasma lipid and apolipoprotein levels in Caucasians of the Rochester Family Heart Study. J Lipid Res (2008) 0.88

Genetic and environmental factors in human osteoporosis from Sub-Saharan to Mediterranean areas. J Bone Miner Metab (2009) 0.85

Genome wide association study of age at menarche in the Japanese population. PLoS One (2013) 0.85

XbaI and PvuII polymorphisms of estrogen receptor 1 gene in females with idiopathic scoliosis: no association with occurrence or clinical form. PLoS One (2013) 0.84

TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women. Menopause (2010) 0.83

Association of estrogen and aromatase gene polymorphisms with systemic lupus erythematosus. Lupus (2010) 0.81

Timing of menarche, childbearing and hysterectomy risk. Maturitas (2008) 0.81

Estrogen receptors genes polymorphisms and age at menarche in idiopathic scoliosis. BMC Musculoskelet Disord (2014) 0.80

Adolescent idiopathic scoliosis: current concepts on neurological and muscular etiologies. Scoliosis Spinal Disord (2016) 0.79

Association analyses suggest multiple interaction effects of the methylenetetrahydrofolate reductase polymorphisms on timing of menarche and natural menopause in white women. Menopause (2010) 0.78

Genome-wide copy number variation association analyses for age at menarche. J Clin Endocrinol Metab (2012) 0.77

Estrogen receptor α polymorphism in boys with constitutional delay of growth and puberty. Ann Pediatr Endocrinol Metab (2013) 0.76

CYP17 MspA1 polymorphism and age at menarche: a meta-analysis. Dis Markers (2008) 0.75

The influence of endogenous and exogenous sex hormones on systemic lupus erythematosus in pre- and postmenopausal women. Prz Menopauzalny (2014) 0.75

Articles by these authors

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia (2010) 4.33

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09

Validation of the Greek translation of the Dundee Ready Education Environment Measure (DREEM). Educ Health (Abingdon) (2010) 1.73

Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis (2010) 1.53

Greece is iodine sufficient. Lancet (2003) 1.48

A heterogeneity-based genome search meta-analysis for autism-spectrum disorders. Mol Psychiatry (2006) 1.39

Industry sponsorship and selection of comparators in randomized clinical trials. Eur J Clin Invest (2009) 1.36

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev (2010) 1.16

Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab (1993) 1.08

Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol (1989) 1.04

Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? Eur J Endocrinol (2001) 1.04

Synopsis of preterm birth genetic association studies: the preterm birth genetics knowledge base (PTBGene). Public Health Genomics (2010) 1.03

Replication and meta-analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry (2012) 1.02

Association of collagen Ialpha 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis. J Bone Miner Res (2001) 1.01

Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease. Growth Horm IGF Res (2001) 1.00

The genetic basis of polycystic ovary syndrome. Eur J Endocrinol (2002) 0.96

The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome. Hum Reprod (2008) 0.95

Combined estrogen receptor alpha and estrogen receptor beta genotypes influence the age of menarche. Hum Reprod (2005) 0.90

Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology (Oxford) (2003) 0.90

Polymorphisms in the 5' flank of COL1A1 gene and osteoporosis: meta-analysis of published studies. Osteoporos Int (2010) 0.90

Mortality in systemic sclerosis. Clin Exp Rheumatol (2008) 0.90

Association of SHBG gene polymorphism with menarche. Mol Hum Reprod (2005) 0.90

Adiponectin in diabetes mellitus. Curr Med Chem (2012) 0.89

Comparison of coronary collateral circulation in diabetic and nondiabetic patients suffering from coronary artery disease. Clin Cardiol (1999) 0.88

Detection of herpes virus DNA in post-operative thyroid tissue specimens of patients with autoimmune thyroid disease. Exp Clin Endocrinol Diabetes (2008) 0.87

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus. Ann Rheum Dis (2008) 0.87

A case of insulin edema with inappropriate hyperaldosteronism. J Endocrinol Invest (2004) 0.87

First-trimester ductus venosus screening for cardiac defects: a meta-analysis. BJOG (2011) 0.85

Risk of myelotoxicity with intravenous cyclophosphamide in patients with systemic lupus erythematosus. Rheumatology (Oxford) (2002) 0.83

Possible reasons for different pattern disappearance of thyroglobulin and thyroid peroxidase autoantibodies in patients with differentiated thyroid carcinoma following total thyroidectomy and iodine-131 ablation. J Endocrinol Invest (2007) 0.83

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints. Ann Rheum Dis (2008) 0.83

The Sp1 COLIA1 gene polymorphism, and not vitamin D receptor or estrogen receptor gene polymorphisms, determines bone mineral density in postmenopausal Greek women. Osteoporos Int (2001) 0.82

T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major. AJR Am J Roentgenol (2000) 0.82

The role of fine-needle aspiration biopsy in the management of patients with thyroid nodules. In Vivo (2005) 0.81

A vision for the European journal of clinical investigation: note from the new editors. Eur J Clin Invest (2010) 0.81

Apolipoprotein E polymorphism is not associated with spinal bone mineral density in peri- and postmenopausal Greek women. Maturitas (2004) 0.80

Turner's syndrome with concomitant hypopituitarism: case report. Hum Reprod (2000) 0.80

Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev (2005) 0.80

Isolated ACTH deficiency associated with Crohn's disease. J Endocrinol Invest (2004) 0.80

A study of the growth-promoting and metabolic effects of growth hormone (GH) in a patient with the "growth without GH" syndrome. Growth Horm IGF Res (2001) 0.80

The role of Fas-mediated apoptosis in thyroid disease. Eur J Endocrinol (2001) 0.78

Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and 400 systematic reviews and meta-analyses. Clin Microbiol Infect (2014) 0.78

Postprandial leptin responses after an oral fat tolerance test: differences in type 2 diabetes. Diabetes Care (2001) 0.78

Correlation of estrogen receptor beta gene polymorphisms with spinal bone mineral density in peri- and post-menopausal Greek women. Maturitas (2005) 0.77

The (TTTA)n polymorphism of aromatase (CYP19) gene is associated with age at menarche. Hum Reprod (2010) 0.77

Management of clinically inapparent adrenal mass. Evid Rep Technol Assess (Summ) (2002) 0.77

Most psychotherapies do not really work, but those that might work should be assessed in biased studies. Epidemiol Psychiatr Sci (2016) 0.76

Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev (2005) 0.76

Fine needle aspiration biopsy-RT-PCR molecular analysis of thyroid nodules: a useful preoperative diagnostic tool. Minerva Endocrinol (2006) 0.76

Gastrectomy and osteomalacia: an association not to be forgotten. Horm Res (1999) 0.75

Hyperinsulinism and weight loss in obese children. Eur J Pediatr (1999) 0.75

Cyclophosphamide in systemic sclerosis: light and shadows. Clin Exp Rheumatol (2004) 0.75

Importance of short-term changes in glycosylated haemoglobin. Br Med J (Clin Res Ed) (1982) 0.75

Hyperprolactinaemia induced by a nonsecreting pituitary adenoma: differential diagnosis with magnetization transfer MRI technique. Clin Endocrinol (Oxf) (2001) 0.75

Increased serum lipoprotein(a) concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency. Ann Clin Biochem (1996) 0.75

Mother-to-child transmission of HIV: developing integration of healthcare programmes with clinical, social and basic research studies. Report of the International Workshop held at Chobe Marina Lodge, Kasane, Botswana, 21-25 January 2003. Acta Paediatr (2003) 0.75

Luteinizing hormone pulsatility in men with damage to the germinal epithelium. Int J Androl (1990) 0.75

The (TAAAA)n polymorphism of the SHBG gene in men with the metabolic syndrome. Exp Clin Endocrinol Diabetes (2010) 0.75

Acute lymphoblastic leukaemia presenting as an enlarged goitre in a pregnant woman with Graves' disease. Eur J Haematol (2000) 0.75

Follicle-stimulating hormone-dependent estrogen secretion by rat Sertoli cells in vitro: modulation by calcium. Acta Endocrinol (Copenh) (1991) 0.75

Magnetization transfer technique: a new diagnostic tool for the postoperative assessment of pituitary adenomas. Clin Endocrinol (Oxf) (2000) 0.75

Sudden hearing loss as the presenting symptom of diabetes mellitus. Diabetes Res Clin Pract (2001) 0.75

Fas and Bcl-2 protein expression in thyrocytes of patients with nodular goiter. Eur J Endocrinol (2001) 0.75

Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist. Fertil Steril (2001) 0.75